Loading…
Details
- Instance of
- type of disease, symptom or sign
- described by source
- Brockhaus and Efron Encyclopedic Dictionary, Small Brockhaus and Efron Encyclopedic Dictionary, Encyclopædia Britannica 11th edition, Collier's New Encyclopedia, 1921, Encyclopædia Britannica First Edition, The Domestic Encyclopædia; Or, A Dictionary Of Facts, And Useful Knowledge, Great Soviet Encyclopedia (1926–1947), Meyers Konversations-Lexikon, 4th edition (1885–1890)
- different from
- Fowlpox virus
- disease transmission process
- droplet infection, contact transmission
- drug or therapy used for treatment
- aciclovir, ganciclovir, zinc oxide
- has cause
- Human herpesvirus 3
- health specialty
- infectious diseases, pediatrics
- ICD-9-CM
- 052, 052.9
- ICPC 2 ID
- A72
- maximal incubation period in humans
- 23
- medical examination
- physical examination, Direct fluorescent antibody, ELISA, real-time polymerase chain reaction
- minimal incubation period in humans
- 6
- symptoms and signs
- vesicle, fever, fatigue, headache, low-grade fever, lymphadenopathy, papule, macula, erosion, itch
- topic's main category
- Category:Chickenpox
Connected on Wikidata
Subject of
- 1911 Encyclopædia Britannica/Chicken-pox
- Collier's New Encyclopedia (1921)/Chicken-Pox
- Domestic Encyclopædia (1802)/Supplement/Chicken-pox
- Encyclopædia Britannica, First Edition/Chicken-Pox
- Pharmacokinetics of Valacyclovir Oral Solution in Children
- Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ (2006-04-30)
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases (2005-11-30)
- A Cross-over, Open-label, Single-group Study to Evaluate the Safety and Immunogenicity of Live Attenuated Varicella Vaccine Skyvaricella Injection (Inj.) Developed by SK Bioscience Company Limited (Co., Ltd) of South Korea in Healthy Volunteer V
- A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
- Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old (2021-09-30)
Nothing in the MetaHistoryBook collection references this item yet.